VBS VetVerlag, Buchhandel und Seminar GmbH
Stories about Medizin
- Language:
- Media:
- Period:
- Period:Total
- more
Sysmex obtains Japanese manufacturing and marketing approval for the first blood-based RAS mutation testing for colorectal cancer
Kobe, Japan (ots) - Sysmex Corporation has obtained Japanese manufacturing and marketing approval for the OncoBEAM(TM) RAS CRC Kit, used for blood-based circulating tumor DNA (ctDNA) molecular testing of mutations in the RAS gene for advanced colorectal cancer patients. With clinically-validated high sensitivity and ...
moreLiquid Biopsy performance comparison of Sysmex Inostics OncoBEAM RAS CRC and BioCartis Idylla ctKRAS testing published in Scientific Reports (Nature Journal)
Hamburg, Germany (ots) - Sysmex Inostics, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, today announces publication of a study comparing the performance of plasma RAS mutation detection by two commercial liquid biopsy testing platforms, the OncoBEAM(TM) ...
moreSysmex Inostics OncoBEAM(TM)-EGFR digital PCR liquid biopsy demonstrates two-fold higher detection of p.T790M mutations in 183 NSCLC patients in comparison study
Hamburg/Baltimore (ots) - Sysmex Inostics announces the publication of clinical research conducted as part of the CIRculating CANcer (CIRCAN) Program at the Lyon Cancer Institute (Lyon, France) comparing the performance of Sysmex Inostics BEAMing (beads, emulsion, amplification, and magnetics) assay for EGFR ...
moreSysmex Inostics' SafeSEQ ER+/HER2- breast cancer panel demonstrates equivalent sensitivity to OncoBEAM(TM) enhanced digital PCR technology for detection of mutations in circulating tumor DNA
Hamburg/Baltimore (ots) - Recent data presented by Dr. Hope S. Rugo from the University of California San Francisco on behalf of investigators in the Translational Breast Cancer Research Consortium at the American Association of Cancer Research 2019 meeting in Atlanta, Georgia demonstrate how Sysmex Inostics' novel ...
moreWorldwide first and only shotgun lipidomics service provider with official GMP certificate
Dresden / Germany (ots) - Good Manufacturing Practices (GMP) ensure safety and quality of pharmaceutical products. Lipotype is the worldwide first and only officially GMP certified shotgun lipidomics service provider for pharmaceutical applications. Quality variations can pose direct threats to patient health - especially in the pharma industry. This is why quality ...
more
Mundipharma EDO GmbH: US FDA Grants Orphan Drug Designation for Tinostamustine in Very Rare Blood Cancer
Basel, Switzerland (ots/PRNewswire) - FOR EX-US MEDICAL AND TRADE MEDIA ONLY - T-cell prolymphocytic leukaemia is an extremely rare and aggressive T-cell leukaemia, with very limited effective treatment options1,2 - Tinostamustine is in very early phase clinical trials to investigate it as a potential future ...
moreSysmex Inostics' OncoBEAM(TM) demonstrates clinical validity and superior performance versus pan-cancer NGS for blood-based mutation detection for hepatocellular carcinoma
Hamburg, Germany (ots) - Data recently published in Clinical Cancer Research (http://ots.de/0ZGZkf) the advantages of using an ultra-high sensitivity test for detection of mutations which may predict therapeutic efficacy for hepatocellular carcinoma (HCC). Sysmex Inostics' OncoBEAM technology, a highly clinically ...
moreSysmex Inostics OncoBEAM(TM) circulating tumor DNA technology demonstrates superior response prediction for advanced pancreatic cancer over standard-of-care protein biomarkers
Hamburg, Germany (ots) - Recent data published in Annals of Oncology (https://academic.oup.com/annonc/advance-article/doi/10.1093/annonc/mdy417/5139593) from a study conducted by Sysmex Inostics and University of Munich indicate that circulating tumor DNA (ctDNA) may offer clinicians higher-resolution information ...
moreSysmex Inostics' OncoBEAM(TM) platform demonstrates superior detection of clinically-relevant mutations for therapy selection and molecular monitoring for lung and colon cancers
Hamburg, Germany (ots) - Data presented at the European Society of Medical Oncology (ESMO) 2018 meeting in Munich, Germany by three clinical oncology research groups demonstrate the importance of a highly sensitive test for detection of clinically-relevant mutations present in circulating tumor DNA (ctDNA) derived ...
moreSysmex Inostics' OncoBEAM(TM) liquid biopsy technology demonstrates utility for clinical management of melanoma patients undergoing treatment with targeted therapy and immune checkpoint inhibitors
Hamburg, Germany (ots) - Sysmex Inostics, a pioneer in blood-based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology, is pleased to announce publication of a study in the Journal of Molecular Oncology highlighting the important clinical value of blood-based ctDNA mutation testing to ...
moreEuropean Society for Medical Oncology (ESMO)
Breast cancer patients use Twitter as a non-medical forum to share their experiences
Lugano/Munich (ots) - Twitter is a place where many cancer patients share and discuss their experiences, a study at the ESMO 2018 Congress reveals, based on analysis of the contents of over 6,000 tweets and retweets about breast cancer. The study was part of a larger, multidisciplinary project to observe the presence of different diseases on social media. The data ...
more
Britta Fuenfstueck appointed as new CEO of the HARTMANN GROUP
moreEuropean Society for Medical Oncology (ESMO)
ESMO emphasises importance of cancer on global health agenda at WHA
Lugano (ots) - - Indication: Picture can be downloaded free of charge under: http://www.presseportal.ch/de/nr/100006433?langid=2 - At the World Health Assembly in Geneva, ESMO delivered two statements positioning cancer as a priority on the WHO global agenda. ESMO advocated the strengthening of health systems to achieve Universal Health Coverage and to provide ...
moreHitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe announces "ScanSync" - a new function for diagnostic ultrasound that reduces the burden on operators - which is to be supported by the "ARIETTA Prologue"
Vienna (ots) - - Indication: Picture can be downloaded free of charge under: http://www.presseportal.ch/de/nr/100012989?langid=2 - This function enables the operation of the diagnostic ultrasound system via auto detection of transducer movement. Hitachi Medical Systems Europe, a wholly owned subsidiary of Hitachi, ...
morePersonnel Change in Executive Board of L&R
Vienna/Rengsdorf (ots) - In January 2018, a change in the Executive Board of manufacturer and supplier of medical devices, Lohmann & Rauscher (L&R), took place after the former Chief Commercial Officer, Markus Sebastian, had resigned. The Advisory Board and the CCO mutually agreed that Markus Sebastian is going to leave the Lohmann & Rauscher Corporate Group by the end of January 2018 to pursue new tasks and face new ...
moreHitachi Medical Systems Europe Holding AG
Hitachi Medical Systems Europe introduces "LISENDO 880", the new premium 2D/4D Cardiovascular Ultrasound System, featuring HDAnalyticsTM by Hitachi at EuroEcho Imaging 2017
Zug (ots) - - Indication: Picture can be downloaded free of charge under: http://www.presseportal.ch/de/nr/100012989?langid=2 - Premium cardiac and vascular imaging rises to a new standard as Hitachi Medical Systems Europe introduces its new premium 2D/4D cardiovascular ultrasound system, the LISENDO 880, featuring ...
moreUMIT - The Health & Life Sciences University
2UMIT Professor Uwe Siebert receives SMDM Award and becomes SMDM President
more
Fresenius Medical Care AG & Co. KGaA
Fresenius Medical Care to acquire NxStage Medical, Inc. to strengthen its vertically integrated dialysis business
Bad Homburg (ots) - Acquisition of NxStage Medical, Inc. would: - position Fresenius Medical Care as a global leader in home dialysis - establish U.S. presence in the critical care space - further enhance clinical outcomes and patient empowerment - support strategic initiative of vertical integration and Care ...
moreB. Braun Medical acquires Dismed's hand sanitizer and intravenous fluid businesses in South Africa / Commitment to growth and local manufacturing for the African healthcare sector
Melsungen/Johannesburg (ots) - On 30 June 2016, B. Braun Medical, the South African subsidiary of the German B. Braun Group, completed its acquisition of Dismed Pharmaceutical (Pty) Ltd and Dismed Criticare (Pty) Ltd, both out of business rescue. With over 600 employees in South Africa, B. Braun specialises in the ...
moreHitachi Medical Systems Europe Holding AG
Hitachi Aloka will present the ARIETTA V70*1 with enhanced Elastography functions
Tokyo, Japan (ots) - At this year's ECR (European Congress of Radiology), March 2-6 in Vienna, Hitachi Aloka will present ARIETTA V70*1 with enhanced Elastography functions. As the pioneer of Elastography, Hitachi Aloka Medical, Ltd. maintains its leadership in this field, providing solutions that can drive Elastography examinations to a new stage by equipping their ...
moreHitachi Medical Systems Europe Holding AG
Hitachi Aloka launches two new, highly flexible Diagnostic Ultrasound Systems, ARIETTA Precision and ARIETTA Prologue
Tokyo, Japan (ots) - At this year's ECR (European Congress of Radiology), March 2-6 in Vienna, Hitachi Aloka Medical launches two new Diagnostic Ultrasound Systems, the ARIETTA Precision and the ARIETTA Prologue. The demand for diagnostic ultrasound examinations in healthcare areas such as advanced acute treatment, ...
moreSafety IVCs: B. Braun Melsungen AG wins patent infringement suit against Becton Dickinson GmbH in Germany
Düsseldorf (ots) - On December 16, 2014, B. Braun Melsungen AG obtained a positive judgment in a law-suit against Becton Dickinson GmbH before the Regional Court Düsseldorf (docket no. 4b O 57/13). According to this judgment, Becton Dickinson may not distribute any longer the product "Venflon Pro Safety" in the ...
moreEuropean Society for Medical Oncology (ESMO)
ESMO announces annual medical oncology congress platform in Europe from 2016
Lugano, Switzerland (ots) - The European Society for Medical Oncology, the pan-European association representing medical oncologists in Europe and beyond, has announced that it will be organising an annual Congress in Europe from 2016. A record 19,809 participants from 134 countries gathered at ESMO 2014 in Madrid to hear the results of trials which included ...
more
Eckert & Ziegler Strahlen und Medizintechnik AG
Eckert & Ziegler awarded contract to produce new type of medicine to fight pancreatic cancer
Berlin (ots) - Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is engaging with a USA based biotech company to become a contract manufacturer for a new type of cancer treatment and is creating a new production plant for this purpose at its Braunschweig location with financial support provided by the customer. The cooperation enfolds a brand-new ...
moreMAQUET AND SWISSTOM GIVE NOTICE OF DISTRIBUTION PARTNERSHIP FOR WESTERN EUROPE
Rastatt, Landquart (ots) - MAQUET and Swisstom are pleased to announce their distribution partnership for the monitoring and diagnostic product Swisstom BB2. Acute Lung Injury is still a leading cause of death for intensive care patients. Swisstom BB2 was especially developed to continuously monitor the lung function of ICU patients undergoing mechanical ventilation. ...
moreNew breast cancer study results published in The Lancet compare targeted radiotherapy during surgery with ZEISS INTRABEAM to traditional post-surgical radiotherapy treatment
Jena (ots) - 5-year results of international TARGIT-A clinical trial support targeted intraoperative radiotherapy (TARGIT) delivered with the ZEISS INTRABEAM as non-inferior to external beam radiotherapy (EBRT) for selected early stage breast cancer patients. Results of the TARGIT-A clinical trial published in The ...
moreMEDICA and COMPAMED 2012 Open This Week: Until Saturday Düsseldorf is Medicine Capital of the World
Düsseldorf (ots) - From Wednesday until Saturday (14 to 17 November 2012) Düsseldorf is again the medicine capital of the world. Opening their doors then are MEDICA 2012, the world's largest medical trade fair with 4,554 exhibitors from 64 countries, and COMPAMED 2012 (until 16 November 2012), the leading international market platform for suppliers to the medical ...
moreEckert & Ziegler Strahlen und Medizintechnik AG
Eckert & Ziegler acquires Vitalea Science Inc. as Part of Strategic Move into Innovative Pharmaceutical Services
Berlin (ots) - Eckert & Ziegler Strahlen- und Medizintechnik AG, through its Californian subsidiary Eckert & Ziegler Isotope Products, Inc. (EZIP), has entered into a definite agreement with Vitalea Science, Inc. for the purchase of all of its stock and assets. Vitalea Science is a pioneering Bioanalytical Contract ...
moreWorld Malaria Day: when a simple initiative conveys great results
Limburgerhof, Germany (ots) - - Interceptor® bed nets key factor for decrease in malaria infection in Jabote community (Brazil) - Positive spiral effect: less malaria, more kids in school - Cross reference: Pictures are available via epa european pressphoto agency and can be downloaded free of charge at: http://www.presseportal.de/pm/16344/basf_se/?keygroup=bild - April 25th marks the fourth annual celebration of World ...
more